ABM Therapeutics
PrivateLast Round
Series B
Extension
May 4, 2023
Total Funding Raised
$50M
Company Overview
ABM Therapeutics is a clinical-stage biopharmaceutical company that develops small molecule targeted therapies for the treatment of brain cancer and cancer metastases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ABM Therapeutics Comparables
Compare ABM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Black Diamond Therapeutics | 78% | |
| Servier | 76% | |
| Suzhou NeuPharma Co., Ltd. | 75% | |
ABM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 4, 2023 | ||||
| Series B | Jan 4, 2022 | ||||
| Series A | Aug 7, 2020 |
ABM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Baidu Ventures | Series B |
| Photon Fund | Series B |
| Sincere Capital | Series B |
| Jiangsu Honghui Equity Investment Management | Series B |
| Kaitai Capital | Series A |
| 健壹资本 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2022
$30M round led by Photon Fund and HighLight Capital
- Aug 7, 2020
$20M round led by 华创资本.
ABM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ABM Therapeutics's valuation, stock price, and market status.